Date:11/18/2010

ailable, risks related to our belief that Masimo rainbow SET enables innovative noninvasive measurements and patient monitoring capabilities providing real-time results for critical blood constituents and physiological parameters that help clinicians to more rapidly assess, diagnose, and treat all patients, risks related to our belief that SpHb detects low or falling hemoglobin levels that could be the result of internal bleeding, risks related to the repeatability of clinical results, as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Media Contacts: Dana Banks

Jason A. La MarcaMasimo Corporation

Prime Healthcare (949) 297-7348

(909) 235-4329dbanks@masimo.com

jlamarca@primehealthcare.comMasimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RR
'/>"/>

SOURCE Masimo; Prime Healthcare Services Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
2. Prime Therapeutics Receives 2011 TIPPS Certification
3. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
4. Prime Therapeutics Announces URAC Accreditation
5. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
6. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
7. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
8. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
9. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
10. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
11. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards